查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2019483

2026-2034年全球口服臨床營養補充品市場規模、佔有率、趨勢和成長分析報告

Global Oral Clinical Nutrition Supplement Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計口服臨床營養補充劑的市場規模將從 2025 年的 70.8 億美元成長到 2034 年的 127.9 億美元，並預計從 2026 年到 2034 年將以 6.79% 的複合年成長率成長。

全球口服臨床營養補充品市場正經歷強勁成長，這主要得益於患者對營養管理和康復日益成長的關注。這些補充劑廣泛用於幫助營養不良、慢性疾病患者以及術後復原。文明病的日益普遍和人口老化是推動市場需求的主要因素。此外，人們對營養在醫療保健中重要性的認知不斷提高，也促進了該市場的擴張。

推動這一成長的主要動力是對針對特定疾病的專用營養產品的需求日益成長。產品配方方面的創新，例如高蛋白和疾病特異性補充劑，正在提高其有效性和接受度。醫療保健服務和居家照護機構的擴張也促進了市場成長。此外，註冊營養師和醫療保健專業人員在推薦營養補充品方面發揮的作用日益增強，也推動了全球營養補充品的普及。

未來，隨著個人化營養概念的進步和產品研發的不斷深入，口服臨床營養補充品市場預計將顯著成長。數位健康科技的整合將有助於更好地監測患者的營養狀況和治療效果。新興市場預計將憑藉不斷提高的健康意識和營養產品獲取管道的改善，帶來巨大的成長機會。此外，研發投入的增加也將推動該領域的創新。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球口服臨床營養補充品市場：依產品類型分類

  • 市場分析、洞察與預測
  • 特殊配方
  • 標準處方

第5章 全球口服臨床營養補充品市場：以劑型分類

  • 市場分析、洞察與預測
  • 液體
  • 半固態
  • 粉末

第6章 全球口服臨床營養補充品市場：依口味分類

  • 市場分析、洞察與預測
  • 調味
  • 無味

第7章 全球口服臨床營養補充品市場：依通路分類

  • 市場分析、洞察與預測
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章 全球口服臨床營養補充品市場：以最終用戶分類

  • 市場分析、洞察與預測
  • 成人
  • 老年人
  • 兒童

第9章 全球口服臨床營養補充品市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • B. Braun Melsungen AG
    • Fresenius Kabi Ltd
    • Pfizer Inc
    • Danone Nutricia
    • Medifood International
    • Medtrition Inc
    • GlaxoSmithKline Plc
    • Perrigo Nutritionals
    • Victus Inc
    • Nestle Health Science
簡介目錄
Product Code: VMR11215732

The Oral Clinical Nutrition Supplement Market size is expected to reach USD 12.79 Billion in 2034 from USD 7.08 Billion (2025) growing at a CAGR of 6.79% during 2026-2034.

The global oral clinical nutrition supplement market is experiencing strong growth due to the increasing focus on patient nutrition and recovery. These supplements are widely used to support individuals with malnutrition, chronic illnesses, and post-surgical recovery. The rising prevalence of lifestyle diseases and the growing aging population are key factors driving market demand. Additionally, increasing awareness about the importance of nutrition in healthcare is contributing to the expansion of this market.

Key drivers include the growing demand for specialized nutrition products tailored to specific medical conditions. Innovations in product formulations, such as high-protein and disease-specific supplements, are enhancing their effectiveness and acceptance. The expansion of healthcare services and homecare settings is also supporting market growth. Furthermore, the increasing role of dietitians and healthcare professionals in recommending nutritional supplements is boosting their adoption worldwide.

In the future, the oral clinical nutrition supplement market is expected to grow significantly with advancements in personalized nutrition and product development. The integration of digital health technologies will enable better monitoring of patient nutrition and outcomes. Emerging markets are anticipated to provide substantial growth opportunities due to rising healthcare awareness and improving access to nutritional products. Additionally, increasing investments in research and development will drive innovation in this sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Specialized Formula
  • Standard Formula

By Dosage Type

  • Liquid
  • Semi-Solid
  • Powder

By Flavor

  • Flavored
  • Unflavored

By Distribution

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End User

  • Adult
  • Geriatric
  • Pediatric

COMPANIES PROFILED

  • B Braun Melsungen AG, Fresenius Kabi Ltd, Pfizer Inc, Danone Nutricia, Medifood International, Medtrition Inc, GlaxoSmithKline plc, Perrigo Nutritionals, Victus Inc, Nestl Health Science
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORAL CLINICAL NUTRITION SUPPLEMENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Specialized Formula Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Standard Formula Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORAL CLINICAL NUTRITION SUPPLEMENT MARKET: BY DOSAGE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Dosage Type
  • 5.2. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Semi-Solid Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Powder Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORAL CLINICAL NUTRITION SUPPLEMENT MARKET: BY FLAVOR 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Flavor
  • 6.2. Flavored Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Unflavored Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORAL CLINICAL NUTRITION SUPPLEMENT MARKET: BY DISTRIBUTION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Distribution
  • 7.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ORAL CLINICAL NUTRITION SUPPLEMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Geriatric Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL ORAL CLINICAL NUTRITION SUPPLEMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product Type
    • 9.2.2 By Dosage Type
    • 9.2.3 By Flavor
    • 9.2.4 By Distribution
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product Type
    • 9.3.2 By Dosage Type
    • 9.3.3 By Flavor
    • 9.3.4 By Distribution
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product Type
    • 9.4.2 By Dosage Type
    • 9.4.3 By Flavor
    • 9.4.4 By Distribution
    • 9.4.5 By End User
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product Type
    • 9.5.2 By Dosage Type
    • 9.5.3 By Flavor
    • 9.5.4 By Distribution
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product Type
    • 9.6.2 By Dosage Type
    • 9.6.3 By Flavor
    • 9.6.4 By Distribution
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ORAL CLINICAL NUTRITION SUPPLEMENT INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 B. Braun Melsungen AG
    • 11.2.2 Fresenius Kabi Ltd
    • 11.2.3 Pfizer Inc
    • 11.2.4 Danone Nutricia
    • 11.2.5 Medifood International
    • 11.2.6 Medtrition Inc
    • 11.2.7 GlaxoSmithKline Plc
    • 11.2.8 Perrigo Nutritionals
    • 11.2.9 Victus Inc
    • 11.2.10 Nestle Health Science